- Elite Trade Club
- Posts
- Education Services Firm Scores a 75%
Education Services Firm Scores a 75%
Adam Garcia
March 26, 2025
Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
Future of Screen Tech (Sponsored)
A tech innovator could enable the mass commercialization of MicroLED displays, securing a partnership with Taiwan’s leading manufacturer. Can this under-the-radar company follow in OLED’s footsteps? Find out more now.
Markets 📈
US stocks bled on Wednesday as investors showed concerns about the impact of tariffs. The market slumped under the pressure from the tech sector.
|
|
Market-Moving News 📈
Grocery
No Eggs in the Basket: Walmart Adapts to Supply Pressures
Walmart (NYSE: WMT) has updated its 2025 Easter meal promotion by removing eggs from its holiday basket due to persistent supply disruptions caused by a bird flu outbreak.
The retailer’s seasonal offering features a kit with nine core ingredients: ham, potatoes, corn, and dessert. Walmart priced the kit to serve eight people for under $6 per person—below last year’s Easter promotion average. Unlike previous years, however, the kit excludes eggs, a shift the company attributed to existing pantry overlap and ongoing supply volatility.
Egg prices surged over recent months as avian flu continued to affect egg-laying hen populations across the country. In response, some grocery chains introduced purchase limits, and restaurants adjusted their menus. Walmart confirmed that while overall availability remains strained in some regions, it has not imposed broad in-store limits on egg purchases. Online orders for 60-count cartons are currently capped at six units.
The company said its grocery business saw mid-single-digit revenue growth in the most recent quarter, aided partly by higher egg prices. While customers continue to navigate inflation-sensitive categories, Walmart’s decision to keep the Easter offering affordable reflects broader efforts to retain value-focused shoppers.
As the nation’s largest grocer, Walmart’s product selections often barometer supply chain stress and consumer expectations.
What’s Musk Planning? (Sponsored)
A Boston based think tank believes we could be just days away from Elon Musk launching his next big venture.
It’s uniquely connected to his new role in the Department of Government Efficiency ("DOGE")… but could have a far reaching impact on every facet of life in America.
They’ve released a fascinating new documentary connecting all the dots on what they believe Elon’s planning and how it could impact your money.
Beverage
FDA Flags Contamination as Coca-Cola Pulls Soda Packs from Stores
The Coca-Cola Company (KO) has initiated a voluntary recall of over 10,000 cans of soda distributed across Illinois and Wisconsin. The move follows a notice from the U.S. Food and Drug Administration (FDA), which flagged the presence of plastic material in select 12-can packs of Coca-Cola products.
Federal officials reclassified the recall as a Class II event, indicating that exposure to the affected products may cause temporary or medically reversible health effects.
Retailers and distributors received formal instructions to remove the affected packs from store shelves and halt further distribution. Coca-Cola continues coordinating with regulatory authorities and partners to ensure swift action and maintain consumer trust.
Packaging teams identified the impacted lots through standard quality assurance checks. The company has not provided details regarding the source of contamination but confirmed that no injuries or health incidents have been reported.
This is not the first time the company has responded proactively to safety concerns. Due to isolated quality issues, Coca-Cola issued product recalls in select international markets.
Consumers who purchased the affected products may return them to the point of purchase or contact Coca-Cola’s customer service for support. The company remains engaged with the FDA and local agencies to finalize recall procedures and strengthen its quality controls.
Junior Mining Watch (Sponsored)
On Behalf of Azincourt Energy Corp
The world’s richest investors—Gates, Bezos, Altman—are pouring billions into nuclear energy. With uranium demand surging, one tiny uranium junior could potentially be the next big winner.
Healthcare
Abbott Laboratories Secures FDA Nod for Coronary IVL System Trial
Abbott Laboratories (NYSE: ABT) received approval from the U.S. Food and Drug Administration to begin a clinical trial for its Coronary Intravascular Lithotripsy (IVL) System. This milestone advances Abbott’s efforts to provide less invasive treatment options for patients with coronary artery disease.
The IVL system aims to address hardened calcium deposits within the arteries by using pressure waves to break them down. This allows for better stent placement and improved blood flow. The technology could offer an alternative for patients who face challenges with traditional interventions.
The system will be tested under an Investigational Device Exemption and will assess the device's safety and effectiveness across various patient groups. The trial adds to Abbott’s growing portfolio of cardiovascular innovations, including recent pacemaker developments and diabetes care technologies.
Recent product approvals and strategic collaborations continue solidifying Abbott’s role in advancing medical technology. The company recently expanded efforts in diabetes management and cardiovascular health through new device rollouts and partnerships.
Abbott has also maintained a steady pace of dividend payments and shareholder programs while pursuing long-term growth in key healthcare segments. Its innovation pipeline continues to evolve, focusing on diagnostics, chronic condition management, and minimally invasive treatments.
Top Winners and Losers 🔥
Lixiang Education Holding ADR [LXEH] $18.21 (+75.10%)
Lixiang Education, which provides private education services in China, saw its share nearly double today. Recently, the company regained compliance with Nasdaq’s minimum market value of publicly held shares, boosting investor confidence.
Worthington Enterprises Inc [WOR] $51.52 (+23.76%)
Industrial manufacturing company Worthington Enterprises rallied after posting strong quarterly results that beat analysts’ expectations on all fronts, including earnings, sales, and operating income.
Alumis Inc [ALMS] $4.92 (+23%)
San Francisco-based Biotech firm Alumis saw its stock thrive after partnering with Japanese Kaken Pharmaceutical to commercialize its drug in Japan. Alumis may receive a total $180 million in a few years, including $40 million in upfront payments.
Airjoule Technologies Corp [AIRJ] $5.29 (-26.73%)
Airjoule Technologies was in free fall today, touching the lowest level this year. The atmospheric energy and water tech company reported a net loss of $14 million in Q4. On top of that, investors dumped AIRJ after it entered into a $30 million stock purchase agreement, planning to sell shares at a discount.
Nyxoah S A [NYXH] $8.91 (-21.36%)
Nyxoah S.A., a European medical technology company, became one of the worst performers today, even though the US FDA approved its sleep apnea treatment. Investors were disappointed to find out that the launch would be delayed by up to two quarters.
Beta Bionics Inc [BBNX] $13.5 (-13.6%)
Beta Bionics, a US medical device company focusing on diabetes, turned bearish after posting unconvincing annual results and guidance for 2025.
Investor Risk Signals (Sponsored)
Perhaps no one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years.
From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024.
And now, Marc Chaikin is predicting the next crash will start March 14, 2026. If you have money in the markets, Chaikin's thesis is a must-see.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
*Standard message/carrier rates may apply.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.